HMGB1 levels correlated with primary tumor progression and distant metastasis, whereas CML-HMGB1 levels were associated with primary tumor progression, lymph node metastasis, distant metastasis, and stage. Here, HMGB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.